A combination of cross-neutralizing antibodies synergizes to prevent SARS-CoV-2 and SARS-CoV pseudovirus infection
H. Liu, M. Yuan, D. Huang, S. Bangaru, C.-C. D. Lee, L. Peng, X. Zhu, D. Nemazee, M. J. van Gils, R. W. Sanders, H.-C. Kornau, S. M. Reincke, H. Pruss, J. Kreye, N. C. Wu, , I. A. Wilson
This study shows that combining cross-neutralizing antibodies CV38-142 and COVA1-16 enhances neutralization of SARS-CoV-2 and SARS-CoV pseudoviruses.
bioRxiv · Feb 11, 2021Microbiology